Garrisi John G, Colls Pere, Ferry Kathleen M, Zheng Xhezong, Garrisi Margarett G, Munné Santiago
The Institute for Reproductive Medicine and Science, Saint Barnabas Medical Center, 3 Regent Street, Livingston, NJ 07039, USA.
Fertil Steril. 2009 Jul;92(1):288-95. doi: 10.1016/j.fertnstert.2008.05.056. Epub 2008 Aug 9.
To determine whether preimplantation genetic diagnosis (PGD) would decrease spontaneous abortion rates in patients with idiopathic recurrent pregnancy loss (RPL).
Controlled clinical study.
IVF center and PGD reference laboratory.
PATIENT(S): Patients with RPL with no known etiology.
INTERVENTION(S): Preimplantation genetic diagnosis by fluorescence in situ hybridization analyzing nine chromosomes.
MAIN OUTCOME MEASURE(S): The spontaneous abortion rate after PGD was compared to the patients' own expected risk of abortion. Patients were evaluated according to the number of previous losses, fertility, and maternal age.
RESULT(S): Preimplantation genetic diagnosis significantly reduced spontaneous abortions in patients with RPL, especially for patients with more than two previous losses (12.8% vs. 35.9% expected). The PGD significantly reduced the rate of spontaneous abortion in both fertile (15.2% vs. 33.8% expected) and infertile patients (13.0% vs. 29.5%), which also achieved similar delivery rates (37% and 34%, respectively). The beneficial effect of PGD was less pronounced in patients <35 years than in patients > or =35 years old (13.6% vs. 34.0% expected). Overall, the PGD reduced the miscarriage rate to a similar baseline of 14%-16% across all maternal ages.
CONCLUSION(S): Preimplantation genetic diagnosis improves pregnancy outcome for women with idiopathic RPL, especially those with more than two previous losses, and >35 years of age, and that improvement is not affected by fertility status.
确定植入前基因诊断(PGD)是否会降低特发性复发性流产(RPL)患者的自然流产率。
对照临床研究。
体外受精中心和PGD参考实验室。
病因不明的RPL患者。
通过荧光原位杂交分析九条染色体进行植入前基因诊断。
将PGD后的自然流产率与患者自身预期的流产风险进行比较。根据既往流产次数、生育能力和产妇年龄对患者进行评估。
植入前基因诊断显著降低了RPL患者的自然流产率,尤其是既往有两次以上流产史的患者(12.8% 对比预期的35.9%)。PGD显著降低了有生育能力患者(15.2% 对比预期的33.8%)和不育患者(13.0% 对比预期的29.5%)的自然流产率,分娩率也相似(分别为37%和34%)。PGD对年龄<35岁患者的有益作用不如对年龄≥35岁患者明显(13.6% 对比预期的34.0%)。总体而言,PGD将所有产妇年龄组的流产率降低到了相似的14%-16%的基线水平。
植入前基因诊断改善了特发性RPL女性的妊娠结局,尤其是既往有两次以上流产史且年龄>35岁的女性,且这种改善不受生育状态的影响。